Kaldalón hf.: Trading Statement for Q1 2025

Reference is made to the Company’s announcement dated 3 December 2024 and to the financial calendar of Kaldalón hf.

As previously disclosed, the Board of Directors of Kaldalón hf. has approved the publication of additional interim information to be released between the Company’s half-year and full-year financial reports. These interim disclosures will take the form of unaudited trading statements for the first and third quarters, providing insight into the Company’s financial performance, balance sheet position, and key developments during the reporting periods.

Attached is the Company’s trading statement for the first quarter of 2025.

For further information, please contact:
Jón Þór Gunnarsson, CEO, Kaldalón hf.
[email protected]

Attachment

• Kaldalon_trading statement Q1-2025 (EN)

You May Also Be Interested In

• Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
• Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and Approximately 29% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick
• Kensho and Classiq Partner to Expand Access to Quantum Software in Taiwan